{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:36:22Z","timestamp":1792812982755,"version":"4.5.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"DOI":"10.1097\/qai.0000000000000063","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T07:56:08Z","timestamp":1384242968000},"page":"340-344","source":"Crossref","is-referenced-by-count":32,"title":["C-Reactive Protein Predicts 96-Week Carotid Intima Media Thickness Progression in HIV-Infected Adults Naive to Antiretroviral Therapy"],"prefix":"10.1097","volume":"65","author":[{"given":"Corrilynn O.","family":"Hileman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris T.","family":"Longenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa L.","family":"Carman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"McComsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210131","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/aje\/kws321","article-title":". Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.","volume":"177","author":"Wada","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R2-14-20210131","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1086\/656415","article-title":". Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.","volume":"51","author":"Puhan","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R3-14-20210131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.","volume":"372","year":"2008","journal-title":"Lancet"},{"key":"R4-14-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1468-1293.2005.00271.x","article-title":"Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.","volume":"6","author":"Krentz","year":"2005","journal-title":"HIV Med"},{"key":"R5-14-20210131","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":". Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease.","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-14-20210131","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/QAD.0b013e32835ce27e","article-title":". Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection.","volume":"27","author":"Stein","year":"2013","journal-title":"AIDS"},{"key":"R8-14-20210131","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3851\/IMP2651","article-title":". Rate and predictors of carotid artery intima media thickness progression in antiretroviral-naive HIV-infected and uninfected adults: a 48-week matched prospective cohort study.","volume":"18","author":"Hileman","year":"2013","journal-title":"Antivir Ther"},{"key":"R11-14-20210131","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1468-1293.2012.01026.x","article-title":". Relationship between total bilirubin and endothelial function, inflammation and oxidative stress in HIV-infected adults on stable antiretroviral therapy.","volume":"13","author":"Hileman","year":"2012","journal-title":"HIV Med"},{"key":"R12-14-20210131","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1089\/aid.2011.0088","article-title":". Omega-3 fatty acids do not improve endothelial function in virologically suppressed HIV-infected men: a randomized placebo-controlled trial.","volume":"28","author":"Hileman","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R13-14-20210131","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3851\/IMP2297","article-title":". Elevated D-dimer is independently associated with endothelial dysfunction: a cross-sectional study in HIV-infected adults on antiretroviral therapy.","volume":"17","author":"Hileman","year":"2012","journal-title":"Antivir Ther"},{"key":"R14-14-20210131","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3851\/IMP1784","article-title":". Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals.","volume":"16","author":"Ross","year":"2011","journal-title":"Antivir Ther"},{"key":"R15-14-20210131","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","article-title":". Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"R16-14-20210131","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/QAD.0b013e32834980f4","article-title":". Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapy.","volume":"25","author":"da Silva","year":"2011","journal-title":"AIDS"},{"key":"R17-14-20210131","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/01.aids.0000171406.53737.f9","article-title":". Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure.","volume":"19","author":"Currier","year":"2005","journal-title":"AIDS"},{"key":"R18-14-20210131","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/QAD.0b013e32811ebf79","article-title":". Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults.","volume":"21","author":"Currier","year":"2007","journal-title":"AIDS"},{"key":"R19-14-20210131","doi-asserted-by":"crossref","first-page":"e000422","DOI":"10.1161\/JAHA.111.000422","article-title":". Carotid intima-media thickness progression in HIV-infected adults occurs preferentially at the carotid bifurcation and is predicted by inflammation.","volume":"1","author":"Hsue","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"R20-14-20210131","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/infdis\/jir134","article-title":". Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.","volume":"203","author":"Boulware","year":"2011","journal-title":"J Infect Dis"},{"key":"R21-14-20210131","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00126334-200302010-00014","article-title":". C-reactive protein is an independent predictor of mortality in women with HIV-1 infection.","volume":"32","author":"Feldman","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-14-20210131","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/archinte.166.1.64","article-title":". C-reactive protein is a marker for human immunodeficiency virus disease progression.","volume":"166","author":"Lau","year":"2006","journal-title":"Arch Intern Med"},{"key":"R23-14-20210131","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QAI.0b013e3181e66216","article-title":". Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.","volume":"55","author":"Tien","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R24-14-20210131","doi-asserted-by":"crossref","first-page":"e24243","DOI":"10.1371\/journal.pone.0024243","article-title":". Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease.","volume":"7","author":"Ledwaba","year":"2012","journal-title":"PLoS One"},{"key":"R25-14-20210131","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.atherosclerosis.2010.11.013","article-title":". Markers of atherosclerosis and inflammation and mortality in patients with HIV infection.","volume":"214","author":"Mangili","year":"2011","journal-title":"Atherosclerosis"},{"key":"R26-14-20210131","doi-asserted-by":"crossref","first-page":"e44454","DOI":"10.1371\/journal.pone.0044454","article-title":". Inflammation, coagulation and cardiovascular disease in HIV-infected individuals.","volume":"7","author":"Duprez","year":"2012","journal-title":"PLoS One"},{"key":"R27-14-20210131","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QAI.0b013e3181a9992c","article-title":"Association of C-reactive protein and HIV infection with acute myocardial infarction.","volume":"51","author":"Triant","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-14-20210131","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":". C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"R29-14-20210131","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","article-title":". C-reactive protein, fibrinogen, and cardiovascular disease prediction.","volume":"367","author":"Kaptoge","year":"2012","journal-title":"N Engl J Med"},{"key":"R30-14-20210131","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.jacc.2010.09.001","article-title":". 2010 ACCFAHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology FoundationAmerican Heart Association Task Force on Practice Guidelines.","volume":"56","author":"Greenland","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R31-14-20210131","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":". Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"R32-14-20210131","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1093\/eurheartj\/ehq238","article-title":". C-reactive protein is a mediator of cardiovascular disease.","volume":"31","author":"Bisoendial","year":"2010","journal-title":"Eur Heart J"},{"key":"R33-14-20210131","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.atherosclerosis.2007.04.053","article-title":"C-reactive protein and atherogenesis: from fatty streak to clinical event.","volume":"195","author":"Bisoendial","year":"2007","journal-title":"Atherosclerosis"},{"key":"R34-14-20210131","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/qjmed\/hcg134","article-title":"C-reactive protein and cardiovascular disease: new insights from an old molecule.","volume":"96","author":"Hirschfield","year":"2003","journal-title":"QJM"},{"key":"R35-14-20210131","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1161\/01.ATV.18.9.1386","article-title":". C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries.","volume":"18","author":"Torzewski","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R36-14-20210131","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0002-9440(10)64051-5","article-title":". Generation of C-reactive protein and complement components in atherosclerotic plaques.","volume":"158","author":"Yasojima","year":"2001","journal-title":"Am J Pathol"},{"key":"R37-14-20210131","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.yjmcc.2003.12.005","article-title":"Effect of C-reactive protein on chemokine expression in human aortic endothelial cells.","volume":"36","author":"Devaraj","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"R38-14-20210131","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1194\/jlr.P600014-JLR200","article-title":". Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects.","volume":"48","author":"Bisoendial","year":"2007","journal-title":"J Lipid Res"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0000000000000063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:36:51Z","timestamp":1620970611000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201403010-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0000000000000063","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,1]]}}}